CHP
ACAD icon

Cable Hill Partners’s Acadia Pharmaceuticals ACAD Stock Holding History

Cable Hill Partners’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,000
Closed -$21K – 779
2018
Q3 		$21K Buy
1,000
+500
+100% +$7.87K 0.01% 304
2018
Q2 		$8K Buy
+500
New +$8.91K ﹤0.01% 521
2018
Q1 		– Sell
-400
Closed -$12K – 882
2017
Q4 		$12K Buy
+400
New +$12.8K 0.01% 520
2016
Q4 		– Hold
0
– – – 717
2016
Q3 		– Sell
-138
Closed -$4.68K – 894
2016
Q2 		$5K Hold
138
– – ﹤0.01% 490
2016
Q1 		$4K Sell
138
-6
-4% -$131 ﹤0.01% 497
2015
Q4 		$6K Sell
144
-5
-3% -$176 ﹤0.01% 428
2015
Q3 		$5K Buy
+149
New +$6.2K ﹤0.01% 485

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return